Citrin Cooperman Acquires Browne Consulting in Major Life Sciences Play

NEW YORK, NY – February 10, 2026 – In a significant move that underscores a deliberate strategy to dominate the life sciences advisory space, Citrin Cooperman Advisors LLC announced today it has acquired Browne Consulting Group LLC, a highly specialized Boston-based firm. The deal brings approximately 60 professionals from Browne, a key player in the biotech and life sciences accounting sector, into the fold of one of the nation's fastest-growing advisory firms.

This acquisition is more than a simple expansion; it represents a strategic deepening of Citrin Cooperman's industry-specific capabilities. By integrating Browne Consulting, known for its deep roots in Boston's thriving biotech ecosystem, the New York-based advisory giant gains a critical foothold and specialized expertise in one of the most complex and lucrative sectors in the modern economy.

"We are thrilled to welcome Browne into the Citrin Cooperman family," said Alan Badey, CEO of Citrin Cooperman Advisors LLC, in a statement. "Browne's deep expertise in Life Sciences and Biotech consulting will accelerate our growth in this high-impact sector. Together, we'll deliver even greater value to our clients as they navigate the complexities of innovation, regulation, and growth in the life sciences ecosystem."

A Strategic Push into a High-Growth Sector

The acquisition is a calculated bet on the continued expansion of the life sciences and biotech industries. These fields, characterized by rapid innovation, significant venture capital investment, and a labyrinthine regulatory landscape, demand a level of financial and operational guidance that goes far beyond traditional accounting. Companies, often scaling from pre-seed funding through complex clinical trials and potential IPOs, require advisors who understand their unique trajectory.

While Citrin Cooperman has long maintained a broad healthcare practice, the integration of Browne Consulting signals a pivot towards hyper-specialization. Browne has built its reputation since its 2016 founding by providing bespoke accounting, strategic finance, and tactical HR support to over 200 venture-backed life science companies. This move allows Citrin Cooperman to immediately offer a mature, battle-tested service platform tailored specifically to the needs of early-stage and scaling biotech, medtech, and diagnostics companies.

This strategic enhancement is critical in a sector where financial missteps or operational inefficiencies can be fatal. By acquiring this specialized knowledge base, Citrin Cooperman positions itself not just as an accountant, but as an indispensable strategic partner to innovators on the cutting edge of medicine and technology.

Riding the Wave of Industry Consolidation

This deal is also a textbook example of a dominant trend within the professional services industry: consolidation driven by the pursuit of niche expertise. Large, full-service firms are increasingly recognizing that the path to high-margin growth lies in acquiring, rather than building, specialized boutique practices that command deep respect within their target industries.

Citrin Cooperman has been a particularly active player in this M&A landscape, completing over 30 acquisitions since 2019, a strategy that intensified after securing private equity backing. This latest transaction with Browne Consulting fits perfectly into that playbook, adding a highly coveted specialty to its sprawling portfolio of services.

Allan Koltin, CEO of Koltin Consulting Group, who advised both firms on the transaction, highlighted the strategic foresight of the merger. "I congratulate both organizations on structuring a deal that not only makes strategic sense but also respects and enhances the unique cultural DNA of each firm," Koltin noted. "Their collective expertise in navigating life sciences opportunities will be a formidable offering for clients seeking trusted partners in a rapidly evolving space."

Koltin's commentary points to the sophisticated nature of modern professional services M&A, where aligning strategy and culture is paramount to unlocking the true value of an acquisition.

More Than a Merger: The Bet on Cultural Fit and Talent

While financial and strategic alignment are crucial, the press release and associated commentary place a heavy emphasis on a less tangible but equally important factor: cultural synergy. In the professional services world, where the primary asset is human talent, a successful integration hinges on retaining key personnel and fostering a collaborative environment.

Warren Browne, founder and CEO of Browne Consulting, echoed this sentiment, emphasizing the cultural alignment that paved the way for the deal. "We couldn't be more excited to join forces with Citrin Cooperman. Our cultural synergies and shared commitment to integrity, innovation, and client success have been evident since our early discussions," he stated. Browne, who will join Citrin Cooperman as a partner, highlighted the powerful combination of his team's specialized experience with the acquirer's national reach and resources.

The focus on a shared "client-first service" ethos and collaborative culture is designed to ensure that the 60 professionals transitioning from Browne feel integrated, not just absorbed. This is critical for maintaining the high-touch, relationship-based service model that made Browne Consulting a success and an attractive target in the first place. Retaining this specialized talent is the key to ensuring the acquisition delivers on its promise of creating a market-leading life sciences practice.

The successful fusion of Citrin Cooperman's scale and Browne Consulting's specialized acumen creates a potent new force in the advisory landscape. For the venture-backed biotech firms navigating the turbulent waters from lab bench to market, this combined entity promises a more robust and comprehensive support system, empowering them to focus on the science while their strategic partners handle the complex business of growth.